BLU-263

· Blueprint Medicines Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLU-263, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis [Phase 2, Phase 3]

See pricing